Bradesco’s CEO Luiz Carlos Trabuco Think Lower Interest Rates Will Help The New Bank Team

Brazil’s Central Bank is going where they haven’t gone before. The Central Bank cut interest rates to seven percent recently, and that news is shaking up the consumer loan divisions of several Brazilian banks. The government’s economic recovery is slower than expected in 2017 so giving Brazilians a chance to borrow money at a lower rate might speed up the recovery. The government is still trying to overhaul the country’s social security. Brazil sovereign credit rating depends on the government passing pension reform before Christmas, but that seems unlikely at this point.

According to recent news reports on folha.uol.com.br, pension reform will come in 2018. But Bradesco, the second largest private bank in the country, is not waiting for the government to get its economic act together. Bradesco recently announced major changes in management, and more changes are on the way, according to CEO Luiz Carlos Trabuco on valor.com.br.

The oldest bank chairman in Brazilian banking history, 91-year-old Lázaro de Mello Brandão, is retiring. Luiz Carlos Trabuco is stepping into his position. Brandão is one of Bradesco’s oldest employees. His banking career started when Bradesco opened its doors more than 70 years ago. He is one of the reasons Bradesco is breaking revenue records. But one of the main reasons for Bradesco success is the new banking systems put in place by Luiz Carlos Trabuco and his executive team. Trabuco has a reputation for being a competent banker who relies on Bradesco’s executive talent. He has a philosophy degree from the University of Sao Paulo and a graduate degree in psychology. Some old Bradesco bankers didn’t think Trabuco would make it as a banker when Luiz was a bank trainee in 1969. He didn’t have an accounting or finance degree. But he did have business sense and a personality that people couldn’t resist.

Read more: PDV exceeded expectations, says Bradesco president

Even though Brazil is going through tough economic times; Bradesco is turning in record profit numbers in 2017. The bank’s stock is trading around $10 a share, and foreign investors are putting the stock into their portfolios again. The Lázaro de Mello Brandão announcement isn’t scaring investors. They know Trabuco can handle the chairmanship as well as function as the president and CEO until the bank announces his replacement. Seven current Bradesco executives are in the hunt for the CEO position. All of those men are loyal employees, and they all have a close relationship with Trabuco.

No one is saying who the best candidate is, but some bank’s employees think IT executive, Mauricio Machado de Minas has the inside track, because of Bradesco’s push to be more digitally banking friendly. Mauricio Machado de Minas is responsible for rolling out Bradesco’s digital banking platform, Next. But acquisition executive Alexandre da Silva Glüher is also in the running for the CEO position. Alexandre da Silva Glüher is responsible for putting the HSBC acquisition together in 2015. Bradesco acquired HSBC’s Brazilian operation. Josué Augusto Pancini, the bank’s operations executive, is also on the list. And so is Andre Cano. Cano is the head of the bank’s human resource department.

But some bank employees think Seguros President Octavio de Lazari will get the job. Seguros is the insurance division of the bank, and Trabuco is a past president of that division. Trabuco was president of Seguros from 2003 to 2009. Chief investment banker, Marcelo Noronha, is in the hunt, and so is Andre Cano. Cano heads up human resources. But chief loan officer Domingos Figueiredo Abreu has a shot at getting the big job in March 2018.

Learn more about Luiz Carlos Trabuco: http://www1.folha.uol.com.br/mercado/2017/10/1926043-lazaro-brandao-sera-substituido-por-trabuco-no-conselho-do-bradesco.shtml

How Amicus Therapeutics Seeks To Help Those With Rare And Orphan Diseases

Amicus Therapeutics, Inc. is a biotechnology firm that is headquartered in Cranbury, New Jersey. The goal of this company is to find cures for disease that are rare and orphan in nature. The main diseases they are currently working to provide cures for are Fabry disease and Pompe disease, both of which are Lysosomal Storage Disorders. They are also working on drug therapies for Epidermolysis Bullosa which is a connective skin disorder which is genetically acquired.

Amicus Therapies was founded in February of 2002. It is now a publically traded company, having attained its initial public offering in 2007. Its stock trades on the NASDAQ under the symbol FOLD. Before going public it was funded by a number of different venture capital companies. The largest ones backing Amicus Therapies were Canaan Partners, New Enterprise Associates, and Radius Ventures.

John Crowley is the chief executive officer and chairman of Amicus Therapeutics. The other two key executives at the company are Chief Operating Officer Bradley Campbell and Chief Financial Officer William Baird (HighTechChronicle). In addition to its corporate headquarters in Cranbury, New Jersey, Amicus Therapeutics now has offices in other countries around the world. Their international headquarters is located in Buckinghamshire, United Kingdom. In Europe, they have offices in Italy, Germany, France, Spain, and the Netherlands. They also have a presence in Asia as they have offices in Tokyo, Japan.

As Amicus Therapeutics does not have any drug manufacturing facilities it has formed partnerships with other companies in the healthcare industry in order to produce the drugs they make. One of Amicus Therapeutics drugs, Gatefold, has been approved for use in Europe and is on the market. This is a type of Migalastat and treats Fabry disease. Another Migalastat, called Migalastat Monotherapy while in development, is approaching the regulatory phase for release in the United States (Facebook).

Another drug that is in phase 2 trials at Amicus Therapeutics is one for Pompe Disease. This drug is presently called ATB200/AT2221 and so far has shown a lot of promise in treating Pompe disease. Three other drugs are also in the pipeline including one that provides an enzyme replacement therapy.

More at http://www.gcreport.com/amicus-therapeutics-announces-new-drug-application/

The Various Passions Of Eli Gershkovitch Alongside His Successful Craft Beer Business

History indicates that the Canadian craft beer era commenced in 1982. The first entrepreneurs opened the doorways to conduct the craft beer business by convincing the government to allow brewing of variable types. The trio’s enterprise collapsed after a couple of years. Their initiative was followed up by the start-up of multiple microbreweries up until the 80’s when the next craft beer wave began. The slow and steady rise of breweries across provinces has led to the opening of craft beer businesses that launch on a weekly basis. The booming business is a magnet for prospective brewers looking to acquire a prestigious name in the Open competition that allows entries from home and professional brewers.

Eli Gershkovitch’s interest in the craft began a few years after leaving school before he started clocking in hours as an attorney. In 1987, Eli Gershkovitch embarked on a tour in Europe, where he sparked his passion to create something of value. He was highly impressed with the Belgian beer and slowly began making underway plans to launch his brewery.

 

Eli Gershkovitch processed licenses for craft beer entrepreneurs, hence earning him invaluable skillsets to set up a business. He settled on starting the facility in a century-old building with a steam heat system to provide brewing power. After 14 months of working with the legal system to ensure the safety of the nearby residential community, Eli Gershkovitch’s business began accumulating substantial benefits.

 

Eli Gershkovitch’s Steamworks Brew Pub launched six craft beers in the first year. He serviced government and private liquor stores. He remarked that growing the business was motivated by the need to meet the growing demands of clients (Blogwebpedia). He bought the adjacent building and grew the seat area from the one hundreds to more than 700. Sponsoring Gastown events in the region redesigned the once dull environment into a hip hang out place where one could drink beer immediately after its brewed.

 

Eli Gershkovitch’s Fortune 500 craft beer business surprises typical suit and tie business owners who are in awe of his casual business demeanor. His cool attitude hides a remarkable business savviness and a fiery passion for life. Apart from his law and craft beer business, Eli Gershkovitch is a licensed pilot (http://www.westender.com/eat-drink/steamworks-is-much-more-than-a-brew-pub-1.879352).